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Sleep/wake behavior is regulated by distinct groups of neurons, such as dopaminergic,
noradrenergic, and orexinergic neurons. Although monoaminergic neurons are usually
considered to be wake-promoting, the role of serotonergic neurons in sleep/wake
behavior remains inconclusive because of the effect of serotonin (5-HT)-deficiency
on brain development and the compensation for inborn 5-HT deficiency by other
sleep/wake-regulating neurons. Here, we performed selective ablation of central 5-HT
neurons in the newly developed Rosa-diphtheria toxin receptor (DTR)-tdTomato mouse
line that was crossed with Pet1Cre/+ mice to examine the role of 5-HT neurons in the
sleep/wake behavior of adult mice. Intracerebroventricular administration of diphtheria
toxin completely ablated tdTomato-positive cells inPet1Cre/+; Rosa-DTR-tdTomatomice.
Electroencephalogram/electromyogram-based sleep/wake analysis demonstrated that
central 5-HT neuron ablation in adult mice decreased the time spent in rapid eye
movement (REM) sleep, which was associated with fewer transitions from non-REM
(NREM) sleep to REM sleep than in control mice. Central 5-HT neuron-ablated mice
showed attenuated wake response to a novel environment and increased theta power
during wakefulness compared to control mice. The current findings indicated that adult
5-HT neurons work to support wakefulness and regulate REM sleep time through a
biased transition from NREM sleep to REM sleep.
Keywords: 5-HT neuron, serotonin, sleep, REMS, diphtheria toxin, brain, mouse model
INTRODUCTION
Sleep/wake behavior is regulated by distinct groups of neurons located from the forebrain to
the medulla (Luppi et al., 2011; Weber and Dan, 2016; Scammell et al., 2017). Among a variety
of neuronal groups, monoaminergic neurons, such as dopaminergic and noradrenergic neurons,
are considered to be wake-promoting neurons (Carter et al., 2010; Eban-Rothschild et al., 2016).
Although serotonin (5-HT)-containing neurons are also regarded as wake-promoting neurons
(Saper et al., 2005; Scammell et al., 2017), the role of serotonergic neurons on sleep/wake behavior
remains inconclusive (Ursin, 2002; Monti, 2011).
Iwasaki et al. Sleep in 5-HT Neuron-Ablated Mice
In early studies conducted by Jouvet et al. dorsal raphe
lesions decreased sleep time in correlation with a reduction
in brain serotonin (Jouvet, 1999). The administration of p-
chlorophenylalanine (PCPA), which is an irreversible inhibitor
of tryptophan hydroxylase (TPH), the rate-limiting enzyme in
the synthesis of 5-HT, induced insomnia, suggesting a role of
the ascending serotonergic system in sleep enhancement (Mouret
et al., 1968; Jouvet, 1999). However, PCPA also block TPH1
and reduced peripheral 5-HT, which is involved in a variety of
functions(El-Merahbi et al., 2015). Furthermore, PCPA reduces
dopamine and noradrenalin levels in the brain(Dailly et al., 2006)
which may alter sleep/wakefulness. Hypothermia after PCPA
treatment may also lead to insomnia (Murray et al., 2015).
Subsequently, unit recordings of raphe nucleus neurons
revealed that their activity was usually high during wakefulness,
low during NREM sleep and almost absent during REM
sleep (McGinty and Harper, 1976; Trulson and Jacobs, 1979;
Jacobs and Fornal, 1999). Pharmacological studies targeting 5-
HT receptors supported the wake-promoting effects of 5-HT
signaling. Systemic administration of a 5-HT1A agonist (Monti
and Jantos, 2003), 5-HT1B agonist (Bjorvatn and Ursin, 1994;
Monti et al., 1995) and 5-HT2 agonist (Dugovic et al., 1989)
increased wakefulness and decreased NREM sleep and REM
sleep. Intracerebroventricular infusion of a 5-HT3 agonist also
increased wakefulness and decreased NREM sleep and REM
sleep (Ponzoni et al., 1993). Among the 14 5-HT receptors in
mice, 5-HT1A, 1B, 2A, 2C, and 7 have been investigated through
the examination of sleep/wake behavior in mice deficient in
these receptors (Hannon and Hoyer, 2008). The time spent in
wakefulness was greater in 5-HT2A- and 2C-deficient mice than
in control mice (Frank et al., 2002; Popa et al., 2005) and was
not altered in 5-HT1A- or 5-HT1B-deficient mice (Boutrel et al.,
1999, 2002), which is seemingly inconsistent with the wake-
promoting effect of agonists for 5-HT1A, 1B, and 2A/C. 5-HT7-
deficient mice also had a normal total wake time (Hedlund et al.,
2005).
Since 5-HT receptors are diverse in their regional and
subcellular distribution and differ in their effect on intracellular
signaling and neuron activity (Hannon and Hoyer, 2008), the
role of the entire 5-HT neuron network in sleep/wake behavior
cannot be characterized by investigating mice that are deficient
in each 5-HT receptor but must be assessed by examining mice
that are deficient in 5-HT or 5-HT neurons. Mice deficient in
Tph2, a rate-limiting enzyme for brain 5-HT, showed normal
time spent in wakefulness, NREM sleep and REM sleep with
a longer NREM sleep duration than control mice (Solarewicz
et al., 2015). The unexpectedly mild sleep phenotype of Tph2-
deficient mice could be due to a compensation for the inborn
deficiency by other sleep/wake-regulating neurons. In addition,
loss of serotonin signaling during brain development modulates
the response of developing thalamocortical axons to netrin-1
(Bonnin et al., 2007) and results in disturbances in the formation
of neural circuits related to sleep/wake behavior, potentially
masking the role of 5-HT in sleep/wake behaviors of wild-type
mice. In fact, acute disruption of Tph2 in the adult raphe nuclei
led to a reduction in time spent in behavioral sleep (Whitney
et al., 2016).
In addition to their effect on wakefulness, 5-HT neurons
have been proposed to play an inhibitory role in the switch
from NREM sleep to REM sleep based on the cessation of
firing of dorsal raphe neurons during REM sleep (McCarley,
2007). Consistent with this finding, microinjection of a 5-HT1A
agonist (Monti and Jantos, 2003) and 5-HT2 agonist (Amici et al.,
2004) into the laterodorsal tegmental nucleus, which contains
REM sleep-active cholinergic neurons, decreased REM sleep. The
increased REM sleep of 5-HT1A-deficient mice (Boutrel et al.,
2002) and 5-HT1B-deficient mice (Boutrel et al., 1999) compared
to that of wild-type mice furthers support the role of 5-HT1A
and 1B in REM sleep suppression. 5-HT7-deficient mice have
exhibited shorter REM sleep time than wild-type mice (Hedlund
et al., 2005).
In addition to 5-HT, 5-HT neurons express vesicular
glutamate transporter 3 (VGLUT3), which is responsible for the
uptake of glutamate into synaptic vesicles (Fu et al., 2010; Hioki
et al., 2010), and 5-HT neurons release glutamate to modulate
reward behavior (Liu et al., 2014). 5-HT neurons in the raphe
nuclei also express some neuropeptides (Okaty et al., 2015).
Thus, neurotransmitters other than 5-HT may be involved in
sleep/wake regulation, and thus the sleep/wake behavior of 5-HT
neuron-ablated mice may be distinct from that of mice deficient
in 5-HT.
To examine the role of 5-HT neurons in sleep/wake
behaviors of adult mice, the effects of 5-HT deficiency on brain
development and on the maturation of sleep/wake behavior
during the early postnatal stage must be excluded. Here,
we performed selective ablation of central 5-HT neurons by
the intracerebroventricular (ICV) administration of diphtheria
toxin (DT) (Murphy, 2011) in the newly developed Pet1Cre/+;
Rosa-diphtheria toxin receptor (DTR)-tdTomato mouse line to
examine sleep/wake behavior based on electroencephalogram
(EEG)/electromyogram (EMG). Ablation of central 5-HT
neurons in adult mice resulted in a decrease in time spent in
REM sleep, which was associated with fewer transitions from
NREM sleep to REM sleep than in control mice, and attenuated
the increase in wakefulness in response to a novel environment.
METHODS
Animals
All of the procedures were conducted in accordance with the
Guidelines for Animal Experiments of University of Tsukuba
and were approved by the Institutional Animal Care and
Use Committee of University of Tsukuba (Approved protocol
ID # 140144). Mice were raised in our breeding colony
under controlled conditions (12-h light/dark cycle, lights on at
9:00A.M., 55± 5% humidity, and ad libitum access to water and
food). Mice were weaned at 4 weeks of age and were housed in
groups of four or five. Pet1-Cre mice (B6.Cg-Tg(Fev-cre)1Esd/J
(Scott et al., 2005; Deneris, 2011) were used in this study. At
any stage of this study, when mice exhibited symptoms of being
severely unhealthy, such as massive weight loss or an inability
to walk, we sacrificed them by cervical dislocation under deep
anesthesia and did not use the data associated with that animal
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in this study. We housed mice and performed all experiments at
23± 2◦C.
Production of
Rosa-loxP-stop-loxP-DTR-tdTomato Mice
For the generation of Rosa26-loxP-stop-loxP-DTR-tdTomato
mice (Rosa-DTR-tdTomato mice), a genomic fragment that
contained the ROSA locus was isolated from C57BL/6 mouse
genomic BAC clone from an RP23 mouse genomic BAC library
(Advanced Geno TEchs Co). The targeting vector had a splice
acceptor (SA), two loxP sequences that were inserted before
the repeated SV40 polyadenylation signal and after the “stop”
sequence that contained the terminator of the yeast His3
gene and SV40 polyadenylation signal. A 1.7-kb fragment of
the FRT-PGK-gb2-neo-FRT-loxP cassette (Gene Bridges) was
inserted after the repeated SV40 polyadenylation signal. After
the second loxP sequence, the targeting vector contained the
coding sequence of the DTR, simian HBEGF followed by IRES
and tdTomato sequences. The targeting vector was linearized and
electroporated into the C57BL/6N ES cell line RENKA. Correctly
targeted clones were injected into the eight-cell stage ICR
mouse embryos, which were cultured to produce blastocysts and
later transferred to pseudopregnant ICR females. The resulting
male chimeric mice were crossed with female C57BL/6N mice
to establish the LSL-DTR-tdTomato; neo line. To remove the
neomycin resistance gene with the FLP-FRT system, LSL-DTR-
tdTomato; neo mice were crossed with Actb-FLP knock-in
mice (Kono et al., 2017). LSL-DTR-tdTomato mice were further
crossed with Pet1Cre mice to establish Pet1Cre; DTR-tdTomato
mice. Gene-modified mice were regularly crossed with C57BL/6J
mice (CLEA Japan) to minimizing genetic drift.
Surgery
For the infusion of DT into the lateral cerebral ventricle, a
cannula was implanted. The guide cannula was prepared by
cutting stainless steel wire (Ziggy’s tubes and wires, 23R304-
36) into 10-mm lengths, and the dummy cannula was made by
cutting a 30-gauge stainless steel tube (Ziggy’s tubes and wires,
#30R304-36) into a 15-mm-long tube and folding one end of the
tube. An injection cannula was also made from 23- and 30-gauge
stainless steel tubes.
Male mice (2.7–5.5 months old) were anesthetized with
isoflurane, and the cranium was exposed. A guide cannula
was inserted under stereotaxic control, which was tilted 30◦ to
the sagittal plane to make room for the implantation of EEG
electrodes. The tip of the cannula was targeted to the following
coordinates: anteroposterior (AP): −0.50mm, mediolateral
(ML): 1.00mm, and dorsoventral (DV):−2.25mm. Immediately
after cannula implantation, each mouse was implanted with an
EEG/EMG electrode containing 4 electrode pins and two flexible
stainless steel wires as reported previously (Komiya et al., 2018).
The electrode pins were lowered to the dura under stereotaxic
control, and the electrode socket was subsequently attached to the
skull with dental cement (3M ESPE, Ketac Cem Aplicap). Two
ipsilateral pins (AP: 0.5mm, ML: 1.77mm, DV: −1.3mm; and
AP: −4.5mm, ML: 1.77mm, DV: −1.3mm) were used for the
EEG recording. For the EMG recording, two stainless wires were
inserted into the neck extensor muscles.
ICV Injection of aCSF and DT
After habituation to the recording conditions, the mice were
injected with 1 µL aCSF through the guide cannula using a 5-
µl syringe (Hamilton #85) under anesthesia with isoflurane. The
aCSF contained 125mMNaCl, 2.5mM KCl, 1.25mMNaH2PO4,
26mMNaHCO3, 10mM glucose, 2mMCaCl2 and 1mMMgCl2.
Twelve to fourteen days after the aCSF injections, 5 ng DT was
injected at a concentration of 5 ng/µL.
EEG/EMG Recording and Analysis
EEG/EMG signaling was obtained and analyzed as previously
described with some modifications (Funato et al., 2010).
EEG/EMG signals were amplified, filtered (EEG: 0.3–300Hz;
EMG: 30–300Hz) with a multi-channel amplifier (NIHON
KODEN, #AB-611J), and digitized at a sampling rate of 250Hz
using an analog-to-digital converter (National Instruments
#PCI-6220). The EEG/EMG data were visualized and semi-
automatically analyzed by MATLAB-based software followed by
visual inspection. Each 20-s epoch was staged into wakefulness,
NREM sleep and REM sleep. Wakefulness was scored based
on the presence of low amplitude, fast EEG activity and high
amplitude, variable EMG activity. NREM sleep was characterized
by high amplitude, delta (1–4Hz)-frequency EEG waves and low
EMG tonus, whereas REM sleep was staged based on theta (6–
9Hz)-dominant EEG oscillations and EMG atonia. EEG/EMG
was subsequently recorded for 11 days after injections. The
recordings on the 9th and 10th day after the injections were
analyzed beginning at ZT0 (9:00A.M.). The total time spent
in wakefulness, NREM sleep, and REM sleep were derived by
summing the total number of 20-s epochs in each state. Mean
episode durations were determined by dividing the total time
spent in each state by the number of episodes of that state.
Epochs that contained movement artifacts were included in the
state totals but excluded from subsequent spectral analysis. EEG
signals were subjected to Fourier transform analysis from 1 to
30Hz with 1-Hz bins using theMATLAB-based custom software.
The EEG power density in each frequency bin was expressed as a
percentage of the mean total EEG power over all frequency bins
and sleep/wake states.
Arousal Response to a Novel Cage
A mouse that was housed in a home cage for at least 1 week
was transferred to a novel cage that contained fresh bedding at
ZT7. The sleep/wake behavior was assessed for 24 h from ZT0. To
assess EEG power density during wakefulness from ZT7 to ZT12,
delta and theta range power were normalized by the total EEG
power over all frequency (1–30Hz) during wakefulness from ZT7
to ZT12. We performed novel cage experiments using 8 mice,
and the EEG/EMG data from 2 mice that contained movement
artifacts were included in state totals but excluded from the
spectral analysis.
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Blood Glucose and Body Temperature
Blood glucose was measured from tail blood using Glutest system
(Sanwa Kagaku) at the late light phase in a fed condition. The
body temperature of a mouse was monitored using a digital
thermometer (BDT-100, Bio Research Center) with a rectal
probe (RET-3, Bio Research Center) without anesthesia and was
acquired in 15 s, including mouse restraint, probe insertion into
the rectum, stabilized temperature recording, and probe removal.
After full acclimatization, the mice only needed to be gently
restrained for the body temperature measurement.
We measured body temperature of Pet1Cre/+; Rosa-DTR-
tdTomato mice at ZT5, 11, 13, and 23 on the 9th and 10th days
after the aCSF injection. Subsequently, we injected DT into the
same Pet1Cre/+; Rosa-DTR-tdTomato mice and measured their
body temperature at ZT5, 11, 13, and 23 on the 9th and 10th days
after the DT injection.
Histological Examination
Mice were deeply anesthetized with isoflurane and transcardially
perfused with PBS followed by 4% paraformaldehyde (PFA) in
PBS. The brains were postfixed in 4% PFA at 4◦C overnight,
cryoprotected in 30% sucrose in PBS for 2 days, embedded in
OCT compound (Sakura Finetech), and stored at −80◦C until
use. The brains were cryosectioned coronally at a thickness of
40µm and stored in tissue cryoprotectant solution at−20◦C.
We used anti-5-HT antibody to visualize 5-HT neurons.
More than 99% of Tph2-positive cells are positive for 5-
HT and vice versa (Hioki et al., 2010). The sections were
rinsed with PBS and incubated in 0.4% Block Ace (Snow
Brand Milk Products) in PBS with 0.1% Tween20 (0.1%
PBST) for 1–2 h at room temperature. This procedure was
followed by overnight incubation with goat anti-5-HT (1:5000;
ImmunoStar #20079) and rabbit anti-RFP (1:2500; MBL
#PM005) antibodies in 0.2% Block Ace in 0.1%PBST overnight
at 4◦C. The sections were rinsed with PBS and then incubated
with AlexaFluor488-conjugated donkey anti-goat IgG (1:1000;
ThermoFisher #A11055) and AlexaFluor594-conjugated donkey
anti-rabbit IgG (1:1000; ThermoFisher # A21207) antibodies
in 0.2% Block Ace in 0.1%PBST overnight at 4◦C. Sections
were rinsed with PBS and mounted with Vectashield mounting
medium with 4’,6-diamidino-2-phenylindole (DAPI) (Vector
Lab, #H-1200). The signals were visualized using a confocal
microscope (Zeiss, #LSM700) with Plan-Apochromat 20x/0.8
M27 (Zeiss). AlexaFluor488 or AlexaFluor594 was excited with
488 or 555 nm laser beams, respectively, and their fluorescence
was obtained 490–587 or 585- nm emission wavelength,
respectively. The sections 4.7, 6.6, and 7.1mm posterior from
bregma were used for cell counting for the dorsal/median raphe,
raphe pallidus and raphe obscurus, respectively. The images of
stained sections were acquired using ZEN 2010 and analyzed
using ZEN Black software (Zeiss). The raphe areas were shown
on the display with the scale in which 1 cm on the display
represents 25µm on the section. Using a line tool of ZEN
software, we marked positive cells at the single fluorescent image
for AlexaFluor488 or AlexaFluor594, separately and subsequently
classified positive cells into 5-HT positive, tdTomato positive and
5-HT/tdTomato positive neurons.
High-Performance Liquid Chromatography
(HPLC)
After cervical dislocation, the brain was immediately removed
and sectioned coronary at 2.4mm posterior from bregma. The
anterior part of the brain was placed on ice and processed for
HPLC analysis, whereas the posterior part of the brain was used
for immunohistochemistry to assess the efficiency of the cell
ablation. The brain was homogenized with 0.2M perchloric acid,
100µM EDTA2·Na in MilliQ (0.5 mL/ 100mg brain) and 200 ng
isoproterenol as an internal standard.
The homogenized sample was left on ice for 30min
and then centrifuged at 20,000 × g for 15min at 0◦C. The
pH of the supernatant was adjusted to be approximately
pH 3, and the supernatant was then filtered through a
0.45µm Millex filter (Millipore). The noradrenalin, 5-HT,
5-HIAA, dopamine, DOPAC, and HVA in the solutions were
separated using an Eicompak SC-5ODS column (Eicom)
and subsequently detected using an electrochemical detector
HTEC-500 (Eicom). The concentration was calculated based
on peak areas which were quantified based on the external
standerd calibration employing linear regression analysis
using LC solution software (Shimadzu). Norepinephrine
bitartratesalt (Sigma N5785), Serotonin creatininesulfate (Sigma
H7752), 5-Hydroxyindoleaceticacid (Sigma H8876), Dopamin
hydrochloride (Sigma H8502), 3,4-Dihydroxyphenylacetic acid
(Sigma 850217), and Homovanillicacid (Sigma H1252) dissolved
in 0.1M acetic acid, 50µM EDTA2·Na in MilliQ were measured
as external standerds in each experiment.
STATISTICAL ANALYSIS
Nomethod of randomization was used in any of the experiments.
The experimenters who staged sleep/wakefulness based on
EEG/EMG were blinded to treatment assignment. Statistical
analysis was performed using SPSS Statistics 22 (IBM). All of
the data were tested for Gaussian distribution and variance.
For group comparisons among the control group and the
groups treated with 2.5 ng and 5 ng DT, the number of
neurons was analyzed using one-way ANOVA followed by post
hoc Tukey’s test. Wake response was analyzed using two-way
ANOVA followed by post hoc Tukey’s test. To compare the
parameters of paired groups, we performed paired t-test with
Bonferroni correction. We performed Wilcoxon matched-pairs
signed-rank test with Bonferroni correction to compare the
parameters of paired groups when the data did not follow
Gaussian distribution.
RESULTS
Ablation of Central 5-HT Neurons in Adult
Mice
Whereas simian or human are sensitive to DT, mice are resistant
to DT (Pappenheimer et al., 1982; Saito et al., 2001). The species
difference in sensitivity to DT depends on the binding affinity
of DT to heparin-binding epidermal growth factor (HBEGF).
Simian and human HBEGF works as the receptor for DT
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(DTR) (Mitamura et al., 1995). To render a specific group
of neurons sensitive to DT in a Cre-dependent manner, we
generated mice in which the Rosa26 locus was modified by
a targeted insertion of a construct that contained loxP-Stop-
loxP-simian HBEGF or DTR, followed by internal ribosomal
entry site (IRES)-tdTomato (Figure 1A). In these mice, DTR
is expressed in the presence of Cre protein in cells that can
be visualized by a fluorescent protein, tdTomato. Rosa26-DTR-
tdTomato mice were crossed with Pet1Cre mice (Scott et al.,
2005; Liu et al., 2010), in which Cre is expressed in 5-HT
neurons, intestinal epithelial cells and pancreatic islet cells
in adult mice (Scott et al., 2005). In the pons of Pet1Cre;
Rosa26-DTR-tdTomato mice, the percentage of 5-HT-postive
cells that were positive for tdTomato was 68.1 ± 2.7 (mean
± SEM) % and 71.2 ± 4.1% in the dorsal and median raphe,
respectively (Figures 1B,C), whereas 4.4 ± 0.8% and 12.6 ±
1.2% of tdTomato-positive cells were negative for 5-HT in
the dorsal and median raphe, respectively. In the medulla, the
percentage of 5-HT-postive cells that were positive for tdTomato
was 63.6 ± 5.1% and 64.1 ± 3.1% in the raphe pallidus and
raphe obscurus, respectively, whereas 9.9 ± 2.8% and 11.9 ±
1.9% of tdTomato-positive cells were negative for 5-HT in
FIGURE 1 | Ablation of central 5-HT neurons. (A) Schematic diagram of the wild-type (WT) Rosa26 locus, PGK-Neo-STOP- HBEGF-tdTomato allele, PGK-Neo
deleted by β-actinFLPase/+ and the allele activated by Pet1-Cre-mediated deletion of the STOP sequence. (B) Leftmost column: Representative images of cells
double positive for 5-HT (green) and tdTomato (magenta) with a merged image (white). Second column: The raphe nuclei contained many cells that were doubly
positive for tdTomato and 5-HT cells in Pet1Cre/+; Rosa-DTR-tdTomato mice without diphtheria toxin (DT) administration. Third column: There were many remaining
cells that were doubly positive for tdTomato and 5-HT after the administration of 2.5 ng DT. Fourth column: After the administration of 5 ng DT, no tdTomato-positive
cells were observed in the raphe nuclei. Arrows indicate cells doubly positive for 5-HT and tdTomato. Arrowheads indicate 5-HT-positive, tdTomato-negative cells.
Rightmost column: After the administration of 5 ng DT, the raphe nuclei contained many 5-HT cells in Pet1+/+; Rosa-DTR-tdTomato mice. Scale bars: 10µm for the
leftmost column, 50µm for other columns. (C) The number of serotonergic neurons in raphe nuclei without (n = 4) and after the administration of 2.5 ng (n = 3–6) and
5 ng DT (n = 5) in Pet1Cre/+; Rosa-DTR-tdTomato mice, and 5 ng DT (n = 3–4) in Pet1+/+; Rosa-DTR-tdTomato mice. One-way ANOVA followed by Tukey’s test.
(D,E) Quantification of 5-HT, 5-HIAA, dopamine, HVA, DOPAC, and noradrenaline in brain homogenates of DT-administered Pet1Cre/+; Rosa-DTR-tdTomato (n = 12)
and Pet1+/+; Rosa-DTR-tdTomato mice (n = 9). Two-tailed t-test. *p < 0.05, **p < 0.01, ***p < 0.001. The data are presented as the group mean ± S.E.M.
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the raphe pallidus and raphe obscurus, respectively, which is
consistent with the results of a previous study (Cerpa et al., 2014)
(Figures 1B,C).
First, we determined the amount of DT necessary to ablate
all tdTomato-positive cells expressing DTR. Since DT ablated
the neurons within 1 week (Wu et al., 2008), we quantified
the remaining tdTomato-positive cells 12 days after ICV DT
administration. When 2.5 ng of DT was administered, many
tdTomato-positive cells survived in the raphe nuclei of the
Pet1Cre/+; Rosa-DTR-tdTomatomice (Figures 1B,C). However, 5
ng of DT completely ablated the tdTomato-positive cells in the
raphe nuclei (Figures 1B,C). After the administration of 5 ng of
DT, the number of 5-HT neurons was decreased by 69% in the
dorsal raphe compared with that in the non-injected mice. The
number of 5-HT neurons in the median raphe, raphe pallidus
and raphe obscurus decreased to 33, 35, and 30%, respectively,
compared with that in the non-injected mice (Figures 1B,C),
consistent with the percentage of all 5-HT neurons negative for
tdTomato (Figures 1B,C). The administration of 10 ng of DT
did not decrease the number of remaining 5-HT neurons (data
not shown). The administration of 5 ng DT did not ablate 5-HT
neurons of Pet1+/+; Rosa-DTR-tdTomatomice in which no DTR
was observed (Figure 1C). At 9 days after the administration of 5
ng of DT, the number of central 5-HT neurons was significantly
lower than that in control mice and similar to that observed 12
days after the DT administration (101.0 ± 4.6 cells in the dorsal
raphe, P = 0.71 vs. the 12th day; 34.0 ± 0.8 cells in the median
raphe, P = 0.11 vs. the 12th day; 11.0 ± 1.7 cells in the raphe
pallidus, P = 0.82 vs. the 12th day; 14.7 ± 1.5 in the raphe
obscurus, P = 0.66 vs. the 12th day, n = 3, one-way ANOVA
with Tukey’s post hoc test). Thus, we used 5 ng of DT to assess
the effect of central 5-HT neurons on sleep/wake behaviors.
We confirmed the reduction in 5-HT levels after the
ablation of 5-HT neurons using high-performance liquid
chromatography (HPLC) of forebrain homogenates. DT-
administered Pet1Cre/+; Rosa-DTR-tdTomato mice showed
that a 55.3 and 46.1% reduction in 5-HT and its metabolite,
5-hydroxyindoleacetic acid (5-HIAA), respectively, compared
with DT-administered Pet1+/+; Rosa-DTR-tdTomato mice
(Figure 1D). To further examine whether central 5-HT
neuron ablation affected the amount of other monoamines,
we quantified the levels of noradrenaline, dopamine, and
dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC)
and homovanillic acid (HVA) in forebrain homogenates,
which were comparable between forebrain homogenates
from DT-administered Pet1Cre/+; Rosa-DTR-tdTomato
and DT-administered Pet1+/+; Rosa-DTR-tdTomato mice
(Figure 1E).
Physical Parameters After Central 5-HT
Neuron Ablation
Since central 5-HT neurons have been reported to be involved
in glucose metabolism and body temperature (Cerpa et al.,
2014; McGlashon et al., 2015), we examined whether
DT administration affected the serum glucose level, body
temperature, and body weight. Although 5 ng DT did not affect
FIGURE 2 | Physical parameters of central 5-HT neuron-ablated mice.
(A) Blood glucose of Pet1Cre/+; Rosa-DTR-tdTomato mice before and after
the administration of 5 ng (n =11) diphtheria toxin (DT). (B) Body weight of
Pet1Cre/+; Rosa-DTR-tdTomato mice (n = 11) before and after the
administration of 5 ng DT. (C) Body temperature of Pet1Cre/+;
Rosa-DTR-tdTomato mice (n = 6) after the administration of 5 ng DT and
aCSF. Paired two-tailed t-test with Bonferroni correction. *p < 0.05. The data
are presented as the group mean ± S.E.M.
the serum glucose level (Figure 2A), slightly but significantly
reduced body weight [change in body weight; −1.1 ± 0.37 g
(mean ± S.E.M), Figure 2B]. We measured body temperature
of Pet1Cre/+; Rosa-DTR-tdTomato mice at ZT5, 11, 13, and 23
on the 9th and 10th days after the DT administration. Mice
are most often asleep at ZT5 and are awake and most active at
ZT13. ZT11 and ZT23 are 1 h before the light-off and light-on,
respectively. DT administration did not alter body temperature
at ZT11, 13 and 23 (change in body temperature;−0.15± 0.15◦C
at ZT11, 0.08 ± 0.19◦C at ZT13, 0.03 ± 0.21◦C at ZT23) but
decreased at ZT5 (change in body temperature; −0.63 ± 0.12◦C,
Figure 2C).
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FIGURE 3 | Sleep/wake behaviors of central 5-HT neuron-ablated mice. (A–C) Total time spent in wakefulness (A), wake episode duration (B) and wake episode
number (C) of aCSF- and diphtheria toxin (DT)-administered Pet1Cre/+; Rosa-DTR-tdTomato mice. (D–F) Total time spent in NREM sleep (NREMS) (D), NREMS
episode duration (E) and NREMS episode number (F) of aCSF- and DT-administered Pet1Cre/+; Rosa-DTR-tdTomato mice. (G–I) Total time spent in REM sleep
(REMS) (G), REMS episode duration (H) and REMS episode number (I) of aCSF- and DT-administered Pet1Cre/+; Rosa-DTR-tdTomato mice. Ten mice in each group.
*p < 0.05. Wilcoxon matched-pairs signed-rank test with Bonferroni correction. The data are presented as the group mean ± S.E.M.
Decreased REM Sleep in Central 5-HT
Neuron-Ablated Mice
We assessed the sleep/wake behaviors of DT-administered
mice 9 and 10 days after DT administration. Central 5-HT
neuron ablation did not alter the time spent in wakefulness
(Figure 3A), the wake episode duration (Figure 3B) or the wake
episode number (Figure 3C). Furthermore, the daily variation
in wake time was similar between artificial cerebrospinal fluid
(aCSF)- and DT-administered Pet1Cre/+; Rosa-DTR-tdTomato
mice (Figure 4A).
DT-administered Pet1Cre/+; Rosa-DTR-tdTomato mice did
not alter total NREM sleep time (Figure 3D). The ablation
of central 5-HT neurons decreased the NREM sleep episode
duration during the dark phase (Figure 3E). There was no
significant difference in the number of NREM sleep episodes
(Figure 3F), and the daily variation in NREM sleep time was
similar between aCSF- and DT-administered Pet1Cre/+; Rosa-
DTR-tdTomatomice (Figure 4B).
The ablation of central 5-HT neurons decreased the
time spent in REM sleep by approximately 24.7% daily
and 53.6% in the dark phase but the difference did not
reach significance during the light phase (Figures 3G, 4C).
Furthermore, central 5-HT neuron ablation increased the
duration of REM sleep episodes during the light phase
(Figure 3H). Finally, DT-administered Pet1Cre/+; Rosa-DTR-
tdTomato mice exhibited fewer REM sleep episodes during
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FIGURE 4 | Daily variation and state transitions of central 5-HT neuron-ablated mice. (A–C) Daily variation in wakefulness (A), NREM sleep (B) and REM sleep (C) in
aCSF- and diphtheria toxin (DT)-administered Pet1Cre/+; Rosa-DTR-tdTomato mice. The values indicate minutes per hour spent in each stage, averaged from
EEG/EMG recordings during two consecutive 24-h periods. (D,E) The values indicate the number of transitions between wakefulness, NREM sleep, and REM sleep
per 24 h in aCSF (D)- and DT (E)-administered Pet1Cre/+; Rosa-DTR-tdTomato mice. (F) The graph indicates transition ratios from NREM sleep to wake and from
NREM sleep to REM sleep. Ten mice in each group. **p < 0.01, ***p < 0.001. Paired two-tailed t-test. The data are presented as the group mean ± S.E.M.
both the light and dark phases than those administered aCSF
(Figure 3I).
The ablation of central 5-HT neurons decreased the
transitions from NREM sleep to REM sleep by 34.7%
(Figures 4D,E). The number of transitions from REM sleep
to wakefulness were also decreased in DT-administered
Pet1Cre/+; Rosa-DTR-tdTomato mice compared with that
in mice given aCSF. Conversely, the transitions from
NREM sleep to wakefulness increased in central 5-HT
neuron-ablated mice (Figures 4D,E). To normalize the
difference in NREM sleep episode number of each mouse,
we calculated the transition ratio of NREM sleep episodes.
DT-administered Pet1Cre/+; Rosa-DTR-tdTomato mice showed
a higher transition ratio from NREM sleep to wake and a
lower transition ratio from NREM sleep to REM sleep than
aCSF-administered Pet1Cre/+; Rosa-DTR-tdTomato mice
(Figure 4F).
Increased Theta Power During
Wakefulness of Central 5-HT
Neuron-Ablated Mice
The EEG spectral analysis of the wake state revealed that
the theta (6–9Hz)-range power density in Pet1Cre/+;
Rosa-DTR-tdTomato mice given DT was significantly
higher than that in aCSF-administered Pet1Cre/+; Rosa-
DTR-tdTomato mice (Figure 5A) without any significant
change in the power density in the delta (1–4Hz) range.
Furthermore, the ablation of central 5-HT neurons did
not alter the EEG spectrum during NREM sleep (theta
range, P = 0.588; delta range, P = 0.524; Figure 5B) or
REM sleep (theta range, P = 0.818; delta range, P = 0.270;
Figure 5C).
Ablation of Central 5-HT Neurons
Attenuated the Arousal Response to a
Novel Environment
To further examine the wake-promoting effect of 5-HT neurons,
we assessed the sleep/wake behavior after the mice were moved
into a novel cage during the light phase, as previously performed
with mice deficient in wake-promoting transmitters such as
histamine, noradrenaline, and orexin (Parmentier et al., 2002;
Hunsley and Palmiter, 2003; Mochizuki et al., 2004). Central
5-HT neuron-ablated mice exhibited a strong arousal response
similar to control mice during the first 1 h after the cage change
at ZT7 (Figures 6A,B), but the time spent in wakefulness of
5-HT-ablated mice was significantly less than that of aCSF-
administered mice during the remaining light phase from
ZT7 to ZT12 (Figures 6A,C), suggesting a shorter duration of
the arousal response in DT-administered Pet1Cre/+; Rosa-DTR-
tdTomato mice. Although DT-administered Pet1Cre/+; Rosa-
DTR-tdTomato mice showed shorter total wake time during the
light phase after cage changes than aCSF-administered Pet1Cre/+;
Rosa-DTR-tdTomato mice, both delta power and theta power
during wakefulness from ZT7 to ZT12 were similar between the
two groups (Figures 6D,E).
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FIGURE 5 | EEG spectrum analysis of central 5-HT neuron-ablated mice. (A)
Power density during wakefulness in aCSF- and diphtheria toxin
(DT)-administered Pet1Cre/+; Rosa-DTR-tdTomato mice. (B) Power density
during NREM sleep in aCSF- and DT-administered Pet1Cre/+;
Rosa-DTR-tdTomato mice. (C) Power density during REM sleep in aCSF- and
DT-administered Pet1Cre/+; Rosa-DTR-tdTomato mice. Ten mice in each
group. Paired two-tailed t-test for delta and theta range density. The data are
presented as the group mean ± S.E.M.
DISCUSSION
The present study demonstrated that the ablation of central 5-HT
neurons in adult mice resulted in a reduction in total REM sleep
time that was associated with fewer transitions from NREM sleep
to REM sleep. Central 5-HT neuron-ablated mice also showed an
attenuated arousal response to a novel environment compared to
control mice.
DT kills cells by inhibiting protein synthesis through ADP-
ribosylation of elongation factor 2 (Murphy, 2011). Since the
amount of DT that is required to ablate target cells differs
depending on the route of administration and the location of
the target cells, we need to determine the minimum amount
of DT that reliably ablates all cells expressing DTR. The Rosa-
DTR-tdTomato mouse is a useful mouse line in which the
tdTomato protein allows for the identification of cells susceptible
to DT and examination of the efficiency of DT-induced cell
ablation.
Pet1 is necessary for the proper differentiation and function
of almost all 5-HT neurons (Wyler et al., 2015, 2016). Although
Pet1-deficient mice have 20–30% of 5-HT neurons compared
with wild-type mice (Kiyasova et al., 2011), the remaining 5-
HT neurons in Pet1-deficient mice lack the expression of genes
such as Tph2, serotonin transporter, organic cation transporter 3
(Slc22a3), and alpha 1 adrenergic receptor that are required for
the differentiation and function of 5-HT neurons (Wyler et al.,
2015, 2016). The presence of tdTomato-negative, 5-HT-positive
cells in Pet1Cre/+; Rosa-DTR-tdTomatomice was consistent with
a previous study using Pet1Cre/+ mice (Cerpa et al., 2014) and
may be caused by imperfect recombination efficiency, which
was suggested by the comparison between Sert-Cre and Pet1-
Cre activity on a floxed vesicular monoamine transporter 2 gene
(Narboux-Nême et al., 2011, 2013).
The current study showed decreased REM sleep after central
5-HT neuron ablation. Consistent with this finding, Pet1-
Cre; Lmx1bflox/flox mice that did not produce central 5-HT
exhibited less REM sleep than wild-type mice (Buchanan and
Richerson, 2010). Since mice deficient in Gs-coupled 5-HT7
exhibited a decrease in the total time of REM sleep (Hedlund
et al., 2005) but no change was observed in mice deficient in
Gq-coupled 5-HT2A (Popa et al., 2005) and 5-HT2C (Frank
et al., 2002), the loss in 5-HT7/Gs-signaling may be crucial
for the observed reduction in REM sleep time after central
5-HT neuron ablation. The increased total REM sleep time
in mice deficient in the Gi-coupled autoreceptors 5-HT1A
(Boutrel et al., 2002) and 5-HT1B (Boutrel et al., 1999) may
be explained by enhanced 5-HT7/Gs signaling subsequent to
the loss of inhibitory autoreceptors. 5-HT neurons are regarded
as “REM-off” neurons, which cease firing during REM sleep
(McGinty and Harper, 1976; Trulson and Jacobs, 1979; Jacobs
and Fornal, 1999). The observation that the loss of “REM-off”
5-HT neurons decreases REM sleep time is counterintuitive.
One potential explanation for these confounding observation is
that the activity of 5-HT neurons during NREM sleep enhances
the tendency for a state transition from NREM sleep toward
REM sleep and away from wakefulness, which could explain
the reduction in the transition from NREM sleep to REM sleep
after central 5-HT neuron ablation observed in the present
study.
5-HT neuron-ablated mice exhibited an attenuated arousal
response to a novel environment compared to the control
mice, which has been reported in mice deficient in histidine
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FIGURE 6 | Arousal response of central 5-HT neuron-ablated mice. (A) Hourly time spent in wakefulness before and after the mouse was transferred into a novel
cage at ZT7. (B) Time spent in wakefulness of aCSF- and diphtheria toxin (DT)-administered Pet1Cre/+; Rosa-DTR-tdTomato mice for 1 h beginning at ZT7. (C) Time
spent in wakefulness of aCSF- and DT-administered Pet1Cre/+; Rosa-DTR-tdTomato mice for 5 h from ZT7 to ZT12. Basal condition, n = 10. Cage change, n = 8.
(D) Delta and (E) theta power density during wakefulness from ZT7 to ZT12. Six mice in each group. *p < 0.05. ###p < 0.001, vs. basal groups. Two-way ANOVA
followed by Tukey’s test. The data are presented as the group mean ± S.E.M.
decarboxylase, a rate-limiting enzyme for the synthesis of
histamine (Parmentier et al., 2002), and in mice deficient in
dopamine β-hydroxylase (Hunsley and Palmiter, 2003). This
finding supports the role of 5-HT neurons as wake-promoting
neurons, consistent with the findings that optogenetic activation
of 5-HT neurons in the dorsal raphe enhanced wakefulness (Ito
et al., 2013), activation of 5-HT neurons using the designer
receptor exclusively activated by designer drugs (DREADD)
system increased regional cerebral blood flow in many cortical
and subcortical areas including the ventral tegmental area
(Giorgi et al., 2017), and 5-HT neurons are usually more
active during wakefulness (McGinty and Harper, 1976; Trulson
and Jacobs, 1979; Jacobs and Fornal, 1999). However, video
monitoring has shown a decrease in sleep time in adult 5-
HT deficiency (Whitney et al., 2016), suggesting that the
effect of 5-HT neuron ablation on sleep/wakefulness could be
different from that of adult 5-HT deficiency, potentially because
glutamate transmission from 5-HT neurons may contribute to
wakefulness (Fu et al., 2010; Hioki et al., 2010; Liu et al.,
2014).
Although the current study failed to detect any changes
in daily total wake time after the ablation of 5-HT neurons,
this result is consistent with previous studies on mice that
were deficient in wake-promoting neurotransmitters, such as
histamine, noradrenalin and orexin, which showed normal total
wake time under basal conditions (Parmentier et al., 2002;
Hunsley and Palmiter, 2003; Mochizuki et al., 2004). Since
multiple wake-promoting circuits work together to maintain
baseline wakefulness, the redundancy in the wake-promoting
system may be able to compensate for the loss of 5-HT neurons
in basal wakefulness but may not be sufficient for a full arousal
response in a novel cage.
The current study also showed higher theta power during
wakefulness of central 5-HT neuron-ablated mice, suggesting
a suppressing effect of 5-HT signaling in hippocampal theta
generation. The theta power during wakefulness usually increases
during exploratory behaviors and may play a role in navigation
(Buzsáki, 2005; Bender et al., 2015). Thus, our results indicates 5-
HT neurons may negatively regulate hippocampal theta rhythm
during navigation and locomotive behavior. Consistently,
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systemic administration of selective agonists for autoreceptors
5-HT1A and 1C enhanced the hippocampal theta of freely
moving animals (Marrosu et al., 1996; Sörman et al., 2011).
In addition, 5-HT fibers were found to be abundant in
the hippocampus of wild-type mice but drastically decreased
in the hippocampus of Pet1-deficient mice (Kiyasova et al.,
2011). Although the theta power of central 5-HT neuron-
ablated mice from ZT7-12 did not reach statistical significance
(Figure 6E), this may be due to a smaller number of mice
examined.
A limitation of the current study was that the role of 5-
HT neurons in sleep/wake behavior could be underestimated
due to the effect of the remaining 5-HT neurons after the
ablation. Total loss of central 5-HT neurons may cause a further
decrease in total REM sleep time and a weaker arousal response
compared to the current results, and could result in an decrease
in total wake time and a increase in total NREM sleep time.
The number of 5-HT neurons was decreased by 68%, and the
5-HT content was decreased by 55%. The smaller reduction
in 5-HT content than in 5-HT neuron number can be partly
explained by 5-HT derived from the blood. Tph2-deficient mice
have 4–7% of the 5-HT found in control mice in the brain or
cerebral cortex (Savelieva et al., 2008; Alenina et al., 2009). A
reduction in negative feedback via autoreceptor 5-HT1a may
also work to increase 5-HT synthesis by the residual 5-HT
neurons.
The raphe pallidus neurons directly connect to the
sympathetic preganglionic neurons which activate the brown
adipose tissue to enhance heat production (Nakamura, 2011).
Thus, ablation of the raphe pallidus neuron may account for
mild reduction in body temperature. The ablation of central
5-HT neurons did not reduce body temperature at ZT11, 13,
and 23 but decreased at ZT5 by 0.6◦C, suggesting that central
5-HT neuron ablation resulted in a decrease in body temperature
during the early-mid light phase. Since energy expenditure
that is associated with locomotion and thermic effect of food is
much higher during the dark phase, than during the light phase
(Abreu-Vieira et al., 2015). Therefore, we think that low body
temperature of central 5-HT neuron-ablated mice during the
light phase suggests that preserved energy expenditure associated
with locomotion and/or food digestion. It is also possible that
central 5-HT neuron ablation disturbs circadian change in body
temperature which is regulated by the suprachiasmatic nucleus
where several 5-HT receptors are expressed (Versteeg et al.,
2015). Compared with our results, larger reduction in body
temperature was reported on 5-HT neuron-ablated Pet1/DTR
mice through intraperitoneal administration of diphtheria toxin
(Cerpa et al., 2014; McGlashon et al., 2015). However, systemic
administration of diphtheria toxin ablated many Pet1-positive
cells, including pancreatic islet cells (Ohta et al., 2011), which
results in a severe diabetic condition (Jia et al., 2014) that is
usually accompanied by hypothermia. Consistently, Tph2-
deficient mice showed a body temperature that was similar to
wild-type mice (Solarewicz et al., 2015).
Since central 5-HT neuron ablation decreased total REM
sleep time and NREM sleep episode duration during the dark
phase but not during the light phase, it is unlikely that the
reduction in body temperature caused a decrease in REM sleep
time and NREM sleep duration in the central 5-HT neuron-
ablated mice. However, we cannot deny the possibility that
this mild reduction in body temperature during the light phase
affects the transition frequency from NREM sleep to REM
sleep and the arousal response in response to a novel cage.
Furthermore, the sleep/wake state and body temperature affect
each other (Murray et al., 2015), making a simple conclusion
difficult to draw. If distinct subgroups of 5-HT neurons separately
regulate sleep/wakefulness and body temperature, a future study
manipulating specific projections of 5-HT neurons may elucidate
this issue by separating the behavioral effects of central 5-
HT neuron ablation. Central 5-HT neuron ablation tends to
decrease both body temperature and body weight. Given that
decreased body temperature is closely correlated with reduced
energy expenditure, central 5-HT neuron-ablatedmicemay show
a reduction in food intake. Further study is needed to examine
the role of central 5-HT neurons in energy metabolism including
food intake and oxygen consumption.
In summary, the current study demonstrates that the Rosa-
DTR-tdTomatomouse is a useful mouse line in which the ablation
efficiency of target cells is easily evaluated and suggests a crucial
role of central 5-HT neurons in regulating REM sleep time,
the transition from NREM sleep to REM sleep and the arousal
response.
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